SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: majormember who wrote (2726)7/20/1999 9:02:00 PM
From: Joe  Respond to of 4140
 
Skane, I concur. Anyone that wants to know can go to the SNRS website and look at the clinical data themselves. It is easy to understand and it summarizes the data from the trials that has been submitted to FDA. I think the shorts are in this for a number of reasons, the primary ones may be associated with factors which have nothing to do with LTK. As TSC pointed out, they have a problem with Thomas James and with Chapman and Presstek. Sounds just plain stupid to me.

Joe



To: majormember who wrote (2726)7/21/1999 4:19:00 AM
From: HeyRainier  Read Replies (3) | Respond to of 4140
 
Sunrise is on the front page of the Wall Street Journal!

"Sunrise Technologies, which is seeking federal approval for a vision-correction system, doesn't have to disclose to a federal panel that many of the investigators who performed the clinical trials own Sunrise stock."

...and the headline on the following page:

Clinical Investigators Who Tested Sunrise Product Held Its Shares


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News